Florio W, Bottai D, Batoni G, Esin S, Pardini M, Maisetta G, Campa M
Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia, Università degli Studi di Pisa, 56127 Pisa, Italy.
Clin Diagn Lab Immunol. 2002 Jul;9(4):846-51. doi: 10.1128/cdli.9.4.846-851.2002.
Diagnosis of tuberculosis is time-consuming and requires infrastructures which are often not available in countries with high incidences of the disease. In the present study, an 82-kDa protein antigen was isolated by affinity chromatography and was identified by peptide mass fingerprinting as isocitrate dehydrogenase II, which is encoded by the icd2 gene of Mycobacterium bovis BCG. The icd2 gene of BCG was cloned by PCR, and the product of recombinant gene expression was purified and analyzed by two-dimensional polyacrylamide gel electrophoresis. The recombinant protein, named rICD2, was tested for its recognition by immunoglobulin G (IgG) antibodies from the sera of 16 patients with tuberculosis (TB) and 23 healthy individuals by Western blotting. The results showed that rICD2 is recognized by IgG antibodies from the sera of all TB patients tested at serum dilutions of > or = 1:640. At a serum dilution of 1:1,280, the sensitivity was 50% and the specificity was 86.9%. These results indicate that rICD2 might represent a candidate for use in a new assay for the serodiagnosis of TB.
结核病的诊断耗时且需要相关基础设施,而在结核病高发国家这些设施往往并不具备。在本研究中,通过亲和层析分离出一种82 kDa的蛋白质抗原,并通过肽质量指纹图谱鉴定为异柠檬酸脱氢酶II,它由卡介苗的icd2基因编码。通过PCR克隆卡介苗的icd2基因,对重组基因表达产物进行纯化,并通过二维聚丙烯酰胺凝胶电泳进行分析。通过蛋白质印迹法检测重组蛋白rICD2是否能被16例结核病患者和23名健康个体血清中的免疫球蛋白G(IgG)抗体识别。结果显示,在血清稀释度≥1:640时,所有检测的结核病患者血清中的IgG抗体均可识别rICD2。在血清稀释度为1:1280时,敏感性为50%,特异性为86.9%。这些结果表明,rICD2可能是用于结核病血清学诊断新检测方法的候选物。